EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) price on Thursday, April 10, rose 5.03% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.80.
A look at the stock’s price movement, the close in the last trading session was $4.57, moving within a range at $4.16 and $4.845. The beta value (5-Year monthly) was 1.408. Turning to its 52-week performance, $23.65 and $3.91 were the 52-week high and 52-week low respectively. Overall, EYPT moved -34.52% over the past month.
EyePoint Pharmaceuticals Inc’s market cap currently stands at around $329.90 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-04.
Analysts have a consensus estimate of 8.84M for the company’s revenue for the quarter, with a low and high estimate of 8.84M and 11.6M respectively. The average forecast suggests down to a -24.38% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 29.03M, representing a -32.90% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that EYPT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 4 recommend EYPT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
EYPT’s current price about -14.16% and -22.99% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.67, while 7-day volatility ratio is 17.28% and 9.51% in the 30-day chart. Further, EyePoint Pharmaceuticals Inc (EYPT) has a beta value of 1.68, and an average true range (ATR) of 0.56. Analysts have given the company’s stock an average 52-week price target of $22, forecast between a low of $22 and high of $22. Looking at the price targets, the low is -358.33% off current price level while to achieve the yearly target high, price needs to move -358.33%. Nonetheless, investors will most likely welcome a -358.33% jump to $22 which is the analysts’ median price.
If we refocus on EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), historical trading data shows that trading volumes averaged 1.04 over the past 10 days and 854.70K over the past 3 months. The company’s latest data on shares outstanding shows there are 68.27 million shares.
The 13.25% of EyePoint Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 96.87% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 10.83 million on 2025-03-14, giving us a short ratio of 13.37. The data shows that as of 2025-03-14 short interest in EyePoint Pharmaceuticals Inc (EYPT) stood at 1779.0001999999997 of shares outstanding, with shares short falling to 11.09 million registered in 2025-02-14. Current price change has pushed the stock -35.57% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the EYPT stock continues to rise going into the next quarter.
